| Literature DB >> 27536207 |
Dagmara Bartczak1, Łukasz Szymański1, Paweł Bodera1, Wanda Stankiewicz1.
Abstract
AIM OF THE STUDY: Due to their prevalence and negative social effects, cardiovascular diseases belong to a group of civilization diseases. Previous research suggests comorbidity of heart diseases, mood disorders and impaired cognitive functioning. The aim of this study was to evaluate the psychoneuroimmunological aspects of functioning in patients diagnosed with cardiovascular diseases.Entities:
Keywords: HRV; cardiovascular diseases; psychoneuroimmunology
Year: 2016 PMID: 27536207 PMCID: PMC4967655 DOI: 10.5114/ceji.2016.60996
Source DB: PubMed Journal: Cent Eur J Immunol ISSN: 1426-3912 Impact factor: 2.085
Fig. 1The spectral component power of HRV in a healthy person
Fig. 3The spectral component power of HRV in an HT and HRD person
Fig. 4Mean values of immune parameters in the studied group
Fig. 5Mean values of psychological tests in the studied group
Percentage of antigen occurrence in the tested population
| Antigen | Tested cell population | Reference value |
|---|---|---|
| CD3 | T-lymphocyte subpopulation | 64-74% |
| CD4 | T helper lymphocyte subpopulation | 41-49% |
| CD8 | cytotoxic T lymphocyte subpopulation | 31-38% |
| CD4/CD8 | Th1/Th2 ratio | 0.6-2.8% |
| CD19 | B lymphocyte subpopulation | 10-15% |
| CD16+CD56+ | NK – natural killer subpopulation | 13-22% |
Correlations between HRV parameters and antigen occurrence
| CD3+ | CD3+ HLA-DR | CD3+ CD4+ | CD3– CD19+ | CD3+ CD8+ | CD3– CD16+ CD56+ | |
|---|---|---|---|---|---|---|
| –0.124 | 0.157 | –0.639 | ||||
| –0.411 | 0.335 | –0.530 | ||||
| 0.216 | 0.029 | 0.695 | –0.111 | –0.188 | –0.118 | |
| –0.343 | –0.025 | –0.533 | ||||
| –0.545 | – | 0.193 | –0.119 | |||
| –0.542 | –0.676 | –0.191 | –0.010 | 0.466 | ||
| 0.264 | 0.304 | 0.583 | –0.153 | –0.008 | –0.178 | |
| –0.304 | 0.009 | –0.497 | ||||
| –0.598 | –0.472 | –0.041 | –0.425 | 0.796** | ||
| 0.200 | –0.068 | 0.217 | –0.191 | –0.104 |
p < 0.05
Correlation between quality of life assessment and HRV parameters
| SDNN | SDANN | rMSSD | pNN50 | LF | HF | LF/HF | TP | LFD | HFD | LF/HFD | LFN | HFN | LFHFN | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EQ5D – pain | quality of life | –0.432 | –0.289 | –0.907** | –0.893** | 0.202 | –0.081 | 0.206 | 0.466 | 0.232 | 0.123 | 0.276 | 0.292 | –0.089 | 0.139 |
| EQ5D – anxiety | –0.132 | 0.132 | –0.451 | –0.372 | 0.279 | 0.815* | –0.346 | 0.795* | –0.086 | 0.378 | –0.278 | 0.732* | 0.838* | –0.359 | |
| SWLS | –0.812* | –0.848* | –0.217 | –0.196 | –0.173 | –0.003 | –0.12 | –0.730* | –0.125 | 0.704 | –0.373 | –0.303 | –0.167 | –0.121 |